Pharmicell Co Ltd banner

Intrinsic Value

The intrinsic value of Pharmicell Co Ltd (005690) under the Base Case is 23 216.23 KRW per share. Compared with the current market price of 8 580 KRW, the stock appears Undervalued by 63% .

The intrinsic value is calculated using valuation multiples.

Do our valuations actually work? See backtest results .

Intrinsic Value
₩23 216.23
Undervaluation 63%
Intrinsic Value
Price ₩8 580
Alert me when Pharmicell Co Ltd is below its intrinsic value
Today ₩18 572.98 · Already reached, the price is 53.8% below it

Pharmicell Co Ltd is cheaper than usual. It was this cheap or cheaper on less than 1% of days in the past 5 years.

Alternatives to Pharmicell Co Ltd

Fundamental Analysis

What Pharmicell Does

Biotechnology Health Care

Pharmicell Co Ltd is a South Korean biotechnology company best known for making stem cell-based medicines and related cell products. Its main work is to develop, manufacture, and sell therapies built from human stem cells, along with biotech products used in medical and cosmetic settings.

Headquarters
Korea KR
Employees
186
IPO date
May 20, 1988
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Pharmicell Co Ltd

Wall St Price Targets

Capital Returns

Competitive Landscape

What is the Intrinsic Value of one Pharmicell Co Ltd stock?

The intrinsic value for Pharmicell Co Ltd (005690) under the Base Case is 23 216.23 KRW.

Is Pharmicell Co Ltd stock undervalued or overvalued?

Compared with the current market price of 8 580 KRW, the stock appears Undervalued by 63% .

Back to Top